These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5572471)

  • 1. Flash methylation and GLC of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin.
    Hammer RH; Wilder BJ; Streiff RR; Mayersdorf A
    J Pharm Sci; 1971 Feb; 60(2):327-9. PubMed ID: 5572471
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography.
    Chang T; Glazko AJ
    J Lab Clin Med; 1970 Jan; 75(1):145-55. PubMed ID: 5410494
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous determination of 5,5-diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin in serum, urine and tissues by gas-liquid chromatography after flash-heater methylation.
    Estas A; Dumont PA
    J Chromatogr; 1973 Aug; 82(2):307-14. PubMed ID: 4725709
    [No Abstract]   [Full Text] [Related]  

  • 4. Thin-layer chromatography of anticonvulsant drugs.
    Pippenger CE; Scott JE; Gillen HW
    Clin Chem; 1969 Mar; 15(3):255-60. PubMed ID: 5773270
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitive GLC procedure simultaneous determination of phenytoin and its major metabolite from plasma following single doses of phenytoin.
    Midha KK; McGilveray IJ; Wilson DL
    J Pharm Sci; 1976 Aug; 65(8):1240-3. PubMed ID: 978445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gas chromatographic/mass spectrometric method for the simultaneous quantitation of 5,5-diphenylhydantoin (phenytoin), its para-hydroxylated metabolite and their stable isotope labelled analogs.
    Van Langenhove A; Costello CE; Biller JE; Biemann K; Browne TR
    Clin Chim Acta; 1981 Sep; 115(3):263-75. PubMed ID: 7028323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined GLC and high-resolution mass spectroscopic analysis of diphenylhydantoin.
    Sabih K; Sabih K
    J Pharm Sci; 1971 Aug; 60(8):1216-20. PubMed ID: 5127096
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gas chromatographic determination of 5,5-diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin in blood].
    Grimmer G; Jacob J; Schäfer H
    Arzneimittelforschung; 1969 Aug; 19(8):1287-90. PubMed ID: 5820294
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications of certain aspects of diphenylhydantoin metabolism.
    Bochner F; Hooper W; Tyrer J; Eadie M
    Proc Aust Assoc Neurol; 1973; 9():171-8. PubMed ID: 4719398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
    Mascher J; Bernhardt W
    Z Neurol; 1973 May; 204(3):179-92. PubMed ID: 4123516
    [No Abstract]   [Full Text] [Related]  

  • 11. Gas chromatographic analysis for anticonvulsant drugs in biologic fluids.
    Pippenger CE; Gillen HW
    Clin Chem; 1969 Jul; 15(7):582-90. PubMed ID: 5794151
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of acute diphenylhydantoin intoxication with plasma levels and metabolite excretion.
    Wilder BJ; Buchanan RA; Serrano EE
    Neurology; 1973 Dec; 23(12):1329-32. PubMed ID: 4796613
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
    Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
    Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass fragmentographic determination of diphenylhydantoin and its main metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, in human plasma.
    Hoppel C; Garle M; Elander M
    J Chromatogr; 1976 Jan; 116(1):53-61. PubMed ID: 1245573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine.
    Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA
    J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000
    [No Abstract]   [Full Text] [Related]  

  • 16. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.
    Atkinson AJ; MacGee J; Strong J; Garteiz D; Gaffney TE
    Biochem Pharmacol; 1970 Aug; 19(8):2483-91. PubMed ID: 5520606
    [No Abstract]   [Full Text] [Related]  

  • 18. Single and multiple ion recording techniques for the analysis of diphenylhydantoin and its major metabolite in plasma.
    Baty JD; Robinson PR
    Biomed Mass Spectrom; 1977 Feb; 4(1):36-41. PubMed ID: 836941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for simultaneous quantification of fosphenytoin, phenytoin and its primary metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin in whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
    Suzuki T; Ogawa T; Ueyama J; Iwai M; Kondo F; Seno H
    Leg Med (Tokyo); 2018 Sep; 34():64-69. PubMed ID: 30195106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical aspects of the metabolism of 5-(4'-fluorophenyl)-5-phenylhydantoin in the rat.
    Poupaert JH; Adline J; Claesen MH; De Laey P; Dumont PA
    J Med Chem; 1979 Sep; 22(9):1140-2. PubMed ID: 490562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.